http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070092297-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83ebcb287b2343acc6752fb97ce7e806
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-82
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
filingDate 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0827d121f1c9fb9be59e4e1385aab067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001c8111dbc39d9514faaf501fdfaece
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4939c71e0c2e5e9569f5e921c645c7a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d93f4b5c84616736a40ebbbc9684cf4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b7628863f850daa3b456db247d3671
publicationDate 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20070092297-A
titleOfInvention 화합물 4 compounds with ion channel activity
abstract The present invention relates to compounds that interact with ion channels. In particular, the present invention has the following formulas I, II, III or IV, wherein X 1 , X 2 , Y, Z, W, R 1 , R 8 , R 10 , L, A, z and n are defined in claim 1 Compounds, stereoisomers, tautomers, racemates, prodrugs, metabolites, or pharmaceutically acceptable salts and / or solvates thereof. The invention also relates to methods of preparing said compounds, pharmaceutical compositions comprising said compounds, and to the use of said compounds in methods of treating human and animal bodies.
priorityDate 2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467960440

Total number of triples: 30.